Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Iqvia Holdings Inc's Business Segments
Iqvia Holdings Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2025
Reportable Segments
2
Largest Segment
Research and Development Solutions
Total Revenue
$ 4,017
Regions Reported
3
Revenue Share by Reportable Segment - Q2 FY2025
- Research and Development Solutions58.9%
- Commercial Solutions41.1%
Revenue by Reportable Segment - Q2 FY2025
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Research and Development Solutions | $ 2,366 | 58.9% |
| Commercial Solutions | $ 1,651 | 41.1% |
Revenue Share by Region - Q2 FY2025
- Americas48.2%
- EMEA30.9%
- Asia Pacific20.9%
Revenue by Geographic Region - Q2 FY2025
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Americas | $ 1,935 | 48.2% |
| EMEA | $ 1,241 | 30.9% |
| Asia Pacific | $ 841 | 20.9% |
Description of Iqvia Holdings Inc
IQVIA Holdings Inc. is a prominent global entity offering comprehensive solutions and services tailored for the biopharmaceutical and healthcare industries. Established through the pivotal merger of Quintiles, a prominent clinical research organization, and IMS Health, a leading healthcare data and analytics firm, IQVIA has cemented its position as a key player in healthcare innovation. The company is headquartered in Durham, North Carolina, and boasts operations across more than 100 countries, showcasing its expansive reach and influence in the global healthcare landscape.
As a leading provider of clinical trial services, IQVIA excels in various domains, including clinical research and development (R&D), clinical trial execution, data management, and patient recruitment. The companys robust capabilities in managing clinical trials allow it to facilitate the development of new pharmaceuticals and therapeutic approaches, ensuring that clients can effectively navigate the complexities of clinical research. By leveraging its advanced technologies and expertise, IQVIA streamlines the clinical trial process, ultimately accelerating the time it takes to bring life-saving products to market.
Beyond clinical trials, IQVIA offers a comprehensive suite of commercial services. These services cover market research, sales and marketing effectiveness, and commercial operations, equipping clients with the insights necessary to succeed in a competitive market. Through its analytical prowess and deep understanding of the healthcare ecosystem, IQVIA helps pharmaceutical and biotech companies optimize their commercial strategies, enhance patient engagement, and improve overall market performance.
A significant asset of IQVIA is its extensive portfolio of proprietary data resources, notably the largest healthcare database globally, which encompasses over 1 billion patient records. This vast database empowers IQVIA to deliver critical insights into healthcare trends, enabling clients to identify specific patient populations for clinical trials and make informed decisions about product development and commercialization strategies. By integrating real-world evidence with advanced analytics, IQVIA allows clients to better understand market dynamics and patient needs to inform their research and development trajectories.
The company serves a diverse clientele that includes pharmaceutical and biotech companies, medical device manufacturers, healthcare providers, payers, and government agencies. IQVIA collaborates closely with each client to provide tailored solutions that align with their specific goals and challenges, ensuring that innovative and effective healthcare solutions are developed and brought to market efficiently.
In addition to its commercial endeavors, IQVIA is deeply committed to fostering positive social impact through various corporate social responsibility initiatives. The company actively participates in programs aimed at addressing health disparities, promoting diversity and inclusion, and supporting underserved communities worldwide. These initiatives reflect IQVIAs dedication to advancing global health and ensuring equitable access to healthcare resources across different populations.
With a global workforce of approximately 67,000 employees, IQVIA is home to a diverse pool of highly educated and skilled professionals, including scientists, clinicians, data analysts, and other experts. The organization boasts a strong culture centered on innovation, collaboration, and continuous learning. IQVIA prioritizes the development of its employees, providing them with the tools and resources necessary to excel in their roles and contribute positively to the healthcare sector. By cultivating a supportive environment that encourages personal and professional growth, IQVIA is well-positioned to meet the evolving demands of its clients and make a meaningful impact on global healthcare.
Through its comprehensive solutions, vast data assets, and commitment to social responsibility, IQVIA Holdings Inc. stands out as a leader in the biopharmaceutical and healthcare industries, driving innovation and enhancing healthcare outcomes worldwide.
As a leading provider of clinical trial services, IQVIA excels in various domains, including clinical research and development (R&D), clinical trial execution, data management, and patient recruitment. The companys robust capabilities in managing clinical trials allow it to facilitate the development of new pharmaceuticals and therapeutic approaches, ensuring that clients can effectively navigate the complexities of clinical research. By leveraging its advanced technologies and expertise, IQVIA streamlines the clinical trial process, ultimately accelerating the time it takes to bring life-saving products to market.
Beyond clinical trials, IQVIA offers a comprehensive suite of commercial services. These services cover market research, sales and marketing effectiveness, and commercial operations, equipping clients with the insights necessary to succeed in a competitive market. Through its analytical prowess and deep understanding of the healthcare ecosystem, IQVIA helps pharmaceutical and biotech companies optimize their commercial strategies, enhance patient engagement, and improve overall market performance.
A significant asset of IQVIA is its extensive portfolio of proprietary data resources, notably the largest healthcare database globally, which encompasses over 1 billion patient records. This vast database empowers IQVIA to deliver critical insights into healthcare trends, enabling clients to identify specific patient populations for clinical trials and make informed decisions about product development and commercialization strategies. By integrating real-world evidence with advanced analytics, IQVIA allows clients to better understand market dynamics and patient needs to inform their research and development trajectories.
The company serves a diverse clientele that includes pharmaceutical and biotech companies, medical device manufacturers, healthcare providers, payers, and government agencies. IQVIA collaborates closely with each client to provide tailored solutions that align with their specific goals and challenges, ensuring that innovative and effective healthcare solutions are developed and brought to market efficiently.
In addition to its commercial endeavors, IQVIA is deeply committed to fostering positive social impact through various corporate social responsibility initiatives. The company actively participates in programs aimed at addressing health disparities, promoting diversity and inclusion, and supporting underserved communities worldwide. These initiatives reflect IQVIAs dedication to advancing global health and ensuring equitable access to healthcare resources across different populations.
With a global workforce of approximately 67,000 employees, IQVIA is home to a diverse pool of highly educated and skilled professionals, including scientists, clinicians, data analysts, and other experts. The organization boasts a strong culture centered on innovation, collaboration, and continuous learning. IQVIA prioritizes the development of its employees, providing them with the tools and resources necessary to excel in their roles and contribute positively to the healthcare sector. By cultivating a supportive environment that encourages personal and professional growth, IQVIA is well-positioned to meet the evolving demands of its clients and make a meaningful impact on global healthcare.
Through its comprehensive solutions, vast data assets, and commitment to social responsibility, IQVIA Holdings Inc. stands out as a leader in the biopharmaceutical and healthcare industries, driving innovation and enhancing healthcare outcomes worldwide.
IQVIA Holdings Inc. is a distinguished multinational company operating at the forefront of healthcare innovation, harnessing the transformative potential of human data science and advanced technologies. The organization is dedicated to enhancing healthcare outcomes while optimizing the efficiency of the healthcare ecosystem.
Segments, Products, and Services Offered by IQVIA Holdings Inc.
1. Research and Development Solutions
This segment is integral to IQVIAs mission of supporting pharmaceutical and biotechnology firms throughout their drug development processes. It encompasses a wide array of services designed to address the complexities of clinical research, including:
- Clinical Trial Design: IQVIA employs advanced methodologies to devise clinical trial frameworks that ensure scientific rigor while maintaining operational efficiency. Their approach minimizes timelines and maximizes the relevance of trial designs to real-world conditions.
- Site Selection: Leveraging extensive databases and sophisticated analytics, IQVIA identifies the most suitable trial sites. This is accomplished by evaluating patient availability, historical performance metrics of sites, and logistical factors that impact trial success.
- Patient Recruitment: Acknowledging the challenges inherent to patient recruitment, IQVIA implements innovative strategies that enhance engagement. This includes harnessing real-world data to pinpoint and reach suitable trial candidates effectively.
- Data Collection and Management: IQVIA offers solutions for the real-time collection of trial data, ensuring compliance with regulatory standards and maintaining data integrity. Their services include streamlined data monitoring processes, which are critical for timely decision-making.
- Regulatory Affairs Services: Recognizing the complexities of global regulatory pathways, IQVIA provides regulatory consulting services. This includes support for compliance and strategies aimed at expediting the approval process for investigational drugs.
Real-World Insights
IQVIAs emphasis on understanding patient behavior extends beyond clinical trials through its Real-World Insights segment, which offers vital insights derived from comprehensive real-world data. Key features include:
- Patient and Provider Insights: By analyzing vast datasets, IQVIA uncovers patterns in treatment utilization, adherence, and health outcomes, equipping clients with a deeper understanding of patient journeys.
- Market Access Solutions: This entails conducting assessments of the pricing landscape and payer perspectives, which are instrumental in crafting competitive pricing strategies and access pathways for new therapies.
- Competitive Intelligence: IQVIA assists clients in navigating competitive markets by analyzing market dynamics and competitor activities, thereby aiding in strategy formulation and product positioning.
- Therapeutic Area Expertise: With specialized teams possessing deep knowledge across various therapeutic areas, IQVIA provides insights that aid in the development and positioning of treatments.
Technology and Analytics Solutions
Harnessing the power of cutting-edge technology, IQVIA offers advanced analytics capabilities and innovative digital health solutions:
- Advanced Data Analytics Platforms: IQVIA provides sophisticated tools that allow stakeholders to derive actionable insights from the vast amounts of data that characterize the healthcare continuum.
- Predictive Analytics: Utilizing machine learning and AI-driven models, IQVIA forecasts disease progression and patient outcomes, significantly enhancing client decision-making processes.
- Digital Health Solutions: This collection of tools includes mobile health applications and patient engagement platforms, designed to boost treatment adherence and enable real-time monitoring of patient experiences.
- IoT and MHealth Integrations: IQVIA utilizes Internet of Things (IoT) technologies for chronic disease management and remote patient monitoring, fostering proactive approaches to care.
Contract Sales and Medical Solutions
This segment is focused on helping healthcare organizations optimize their sales strategies and succeed within a competitive landscape. Key services offered include:
- Contract Sales Organization (CSO) Services: IQVIA provides outsourced sales teams trained to promote pharmaceutical and medical products effectively, significantly reducing time to market and enhancing sales efficiency.
- Medical Affairs Support: This encompasses a variety of services, including medical writing, clinical data communications, and strategic guidance related to product claims, aligning them with regulatory standards.
- Promotional & Educational Materials: IQVIA creates tailored promotional content and educational resources directed toward healthcare professionals and patients, enhancing awareness and understanding of medical products.
- Regulatory Compliance Consulting: IQVIA offers expertise in navigating the intricacies of compliance to ensure that all promotional and educational activities adhere to existing laws and regulations.
Conclusion
In summary, IQVIA Holdings Inc. stands out as a critical player in the evolving landscape of global healthcare through its diverse and interconnected segments. With a comprehensive suite of research and development solutions, real-world insights, technology-driven analytics, and contract sales and medical solutions, IQVIA demonstrates a commitment to addressing complex healthcare challenges. This multidimensional approach, integrating advanced technology and data-driven insights with deep industry expertise, positions IQVIA as a pivotal force dedicated to delivering innovative therapies, ultimately leading to improved patient outcomes.
Segments, Products, and Services Offered by IQVIA Holdings Inc.
1. Research and Development Solutions
This segment is integral to IQVIAs mission of supporting pharmaceutical and biotechnology firms throughout their drug development processes. It encompasses a wide array of services designed to address the complexities of clinical research, including:
- Clinical Trial Design: IQVIA employs advanced methodologies to devise clinical trial frameworks that ensure scientific rigor while maintaining operational efficiency. Their approach minimizes timelines and maximizes the relevance of trial designs to real-world conditions.
- Site Selection: Leveraging extensive databases and sophisticated analytics, IQVIA identifies the most suitable trial sites. This is accomplished by evaluating patient availability, historical performance metrics of sites, and logistical factors that impact trial success.
- Patient Recruitment: Acknowledging the challenges inherent to patient recruitment, IQVIA implements innovative strategies that enhance engagement. This includes harnessing real-world data to pinpoint and reach suitable trial candidates effectively.
- Data Collection and Management: IQVIA offers solutions for the real-time collection of trial data, ensuring compliance with regulatory standards and maintaining data integrity. Their services include streamlined data monitoring processes, which are critical for timely decision-making.
- Regulatory Affairs Services: Recognizing the complexities of global regulatory pathways, IQVIA provides regulatory consulting services. This includes support for compliance and strategies aimed at expediting the approval process for investigational drugs.
Real-World Insights
IQVIAs emphasis on understanding patient behavior extends beyond clinical trials through its Real-World Insights segment, which offers vital insights derived from comprehensive real-world data. Key features include:
- Patient and Provider Insights: By analyzing vast datasets, IQVIA uncovers patterns in treatment utilization, adherence, and health outcomes, equipping clients with a deeper understanding of patient journeys.
- Market Access Solutions: This entails conducting assessments of the pricing landscape and payer perspectives, which are instrumental in crafting competitive pricing strategies and access pathways for new therapies.
- Competitive Intelligence: IQVIA assists clients in navigating competitive markets by analyzing market dynamics and competitor activities, thereby aiding in strategy formulation and product positioning.
- Therapeutic Area Expertise: With specialized teams possessing deep knowledge across various therapeutic areas, IQVIA provides insights that aid in the development and positioning of treatments.
Technology and Analytics Solutions
Harnessing the power of cutting-edge technology, IQVIA offers advanced analytics capabilities and innovative digital health solutions:
- Advanced Data Analytics Platforms: IQVIA provides sophisticated tools that allow stakeholders to derive actionable insights from the vast amounts of data that characterize the healthcare continuum.
- Predictive Analytics: Utilizing machine learning and AI-driven models, IQVIA forecasts disease progression and patient outcomes, significantly enhancing client decision-making processes.
- Digital Health Solutions: This collection of tools includes mobile health applications and patient engagement platforms, designed to boost treatment adherence and enable real-time monitoring of patient experiences.
- IoT and MHealth Integrations: IQVIA utilizes Internet of Things (IoT) technologies for chronic disease management and remote patient monitoring, fostering proactive approaches to care.
Contract Sales and Medical Solutions
This segment is focused on helping healthcare organizations optimize their sales strategies and succeed within a competitive landscape. Key services offered include:
- Contract Sales Organization (CSO) Services: IQVIA provides outsourced sales teams trained to promote pharmaceutical and medical products effectively, significantly reducing time to market and enhancing sales efficiency.
- Medical Affairs Support: This encompasses a variety of services, including medical writing, clinical data communications, and strategic guidance related to product claims, aligning them with regulatory standards.
- Promotional & Educational Materials: IQVIA creates tailored promotional content and educational resources directed toward healthcare professionals and patients, enhancing awareness and understanding of medical products.
- Regulatory Compliance Consulting: IQVIA offers expertise in navigating the intricacies of compliance to ensure that all promotional and educational activities adhere to existing laws and regulations.
Conclusion
In summary, IQVIA Holdings Inc. stands out as a critical player in the evolving landscape of global healthcare through its diverse and interconnected segments. With a comprehensive suite of research and development solutions, real-world insights, technology-driven analytics, and contract sales and medical solutions, IQVIA demonstrates a commitment to addressing complex healthcare challenges. This multidimensional approach, integrating advanced technology and data-driven insights with deep industry expertise, positions IQVIA as a pivotal force dedicated to delivering innovative therapies, ultimately leading to improved patient outcomes.